DANAHER CORP /DE/ (DHR) Earnings History

8 quarters held0/3 transcripts analyzed3/40 figures attested
Connect your agent
PeriodRevenueYoYNet incomeEPS (dil.)Filed
Q2 2026$6.3B+5.5%$870.0M$1.23Jul 20, 2026
LATESTEarnings filing (8-K)10-QFiled Jul 20, 2026, 5:55 PM ET
Earnings call · Jul 21, 2026deck
Q2 FY26YoY6M FY26
Revenue$6.3B+5.5%$12.2B
Net income$870.0M1+56.8%$1.9B
Op income$1.1B+48.3%$2.5B
EPS (dil.)$1.231+59.7%$2.68
EPS (basic)$1.23+60.0%–
Gross margin57.6%-1.7pp
Op margin18.0%+5.2pp
Net margin13.9%+4.5pp
  1. [1] “Net earnings were $870 million, or $1.23 per diluted common share, up 60% year-over-year.” view source

Guidance & outlook

Management guidance

Q2 2026

fy_current

other
3—4
eps_diluted
$8.45—$8.60

q_next

other
2—3

Special items & operational metrics

Operational metrics

Q2 2026
Respiratory testing sales
250.0M
-50.0% YoY
Prior year: 500.0M
USD
Q1 2026$6.0B+3.7%$1.0B$1.45Apr 21, 2026
10-QFiled Apr 20, 2026, 5:44 PM ET
Earnings call · Apr 21, 2026deck
Q1 FY26YoY
Revenue$6.0B1+3.7%
Net income$1.0B+7.9%
Op income––
EPS (dil.)$1.45+9.8%
EPS (basic)––
Net margin17.3%+0.7pp
  1. [1] “Sales $ 5,951” view source
Q4 2025––––Jan 28, 2026
10-KFiled Jan 27, 2026, 5:37 PM ET
Earnings call · Jan 28, 2026
Q4 FY25YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q3 2025$6.1B+4.5%$908.0M$1.27Oct 21, 2025
Earnings filing (8-K)10-QFiled Oct 20, 2025, 5:39 PM ET
Q3 FY25YoY9M FY25
Revenue$6.1B+4.5%$17.7B
Net income$908.0M+11.0%$2.4B
Op income$1.2B+20.5%$3.2B
EPS (dil.)$1.27+13.4%$3.37
EPS (basic)$1.28+13.3%$3.38
Gross margin58.2%-0.5pp
Op margin19.1%+2.5pp
Net margin15.0%+0.9pp
Q2 2025$5.9B+3.5%$555.0M$0.77Jul 22, 2025
Earnings filing (8-K)10-QFiled Jul 21, 2025, 5:47 PM ET
Q2 FY25YoY6M FY25
Revenue$5.9B+3.5%$11.7B
Net income$555.0M-38.8%$1.5B
Op income$760.0M-35.0%$2.0B
EPS (dil.)$0.77-36.9%$2.10
EPS (basic)$0.77-37.4%$2.11
Gross margin59.4%-0.3pp
Op margin12.8%-7.5pp
Net margin9.3%-6.4pp
Q1 2025––––Apr 22, 2025
10-QFiled Apr 22, 2025, 6:08 AM ET
Q1 FY25YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q4 2024––––Jan 29, 2025
10-KFiled Jan 28, 2025, 5:45 PM ET
Q4 FY24YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––
Q3 2024––––Oct 22, 2024
Q3 FY24YoY
Revenue––
Net income––
Op income––
EPS (dil.)––
EPS (basic)––

IR event calendar

This company's IR event calendar has not been harvested yet — an empty result here does NOT mean the company has no IR events.

Filing coverage

64 filings indexed · 62,626 XBRL facts
FilingDatePeriodSectionsTables
8-K2026-08-03–40
10-Q2026-07-21–3969
8-K2026-07-21–90
8-K2026-06-03–20
8-K2026-05-07–20
8-K2026-04-29–10
10-Q2026-04-21–3747
8-K2026-04-21–100
8-K2026-04-17–20
10-K2026-02-24FY 6785

Showing the latest 10 of 64 — the full set is in the API.

Related Research

Analysis

Why Danaher's Worst Margins in Years Hide Its Best Cash Flows

Analysis

Amphenol's 52% Growth Created a $10.5B Question. The 10-K Answers It.

Analysis

Medical Device ROIC Rankings: Why Abbott's 26% Beats Medtronic's 7% (The Gross Margin Paradox)